行情

NSPR

NSPR

Inspiremd
NASDAQ

实时行情|Nasdaq Last Sale

2.260
0.000
0.00%
盘后: 2.170 -0.09 -3.98% 19:20 05/20 EDT
开盘
2.320
昨收
2.260
最高
2.423
最低
2.190
成交量
3.27万
成交额
0
52周最高
6.82
52周最低
1.910
市值
1,881.04万
市盈率(TTM)
-1.0862
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解NSPR最新的财务预测,通过NSPR每股收益,每股净资产,每股现金流等数据分析Inspiremd近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测NSPR价格均价为5.25,最高价位5.25,最低价为5.25。
最高5.25
均价5.25
最低5.25
现价2.260
EPS
实际EPS
预期EPS
-0.69-0.52-0.34-0.17
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 23
机构持股: 16.96万
持股比例: 2.04%
总股本: 832.32万
类型机构数股数
增持
2
2,487
建仓
3
3,055
减持
2
604
平仓
5
3.69万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.35%
医疗设备和用品
+0.36%
高管信息
Non-Executive Chairman/Independent Director
Paul Stuka
President/Chief Executive Officer/Director
Marvin Slosman
Chief Financial Officer/Chief Administrative Officer/Treasurer/Secretary/IR Contact Officer
Craig Shore
Independent Director
Kathryn Arnold
Independent Director
Michael Berman
Independent Director
Thomas Kester
Independent Director
Campbell Rogers
Independent Director
Gary Roubin
暂无数据
暂无数据
NSPR 简况
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

微牛提供InspireMD Inc(NASDAQ-NSPR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NSPR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NSPR股票基本功能。